EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 39 / No 10 (Octobre 2023) Med Sci (Paris), 39 10 (2023) 703-706 References
Open Access
Issue
Med Sci (Paris)
Volume 39, Number 10, Octobre 2023
Page(s) 703 - 706
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2023115
Published online 09 November 2023
  1. NaikS, BouladouxN, LinehanJL, et al. Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature 2015 ; 520 : 104–108. [CrossRef] [PubMed] [Google Scholar]
  2. Linehan JL, Harrison OJ, Han SJ, et al. Non-classical immunity controls microbiota impact on skin immunity and tissue repair. Cell 2018; 172 : 784–96 e718. [CrossRef] [PubMed] [Google Scholar]
  3. Chen YE, Bousbaine D, Veinbachs A, et al. Engineered skin bacteria induce antitumor T cell responses against melanoma. Science 2023; 380 : 203–10. [CrossRef] [PubMed] [Google Scholar]
  4. Sahin U, Oehm P, Derhovanessian E, et al. An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. Nature 2020; 585 : 107–12. [CrossRef] [PubMed] [Google Scholar]
  5. Youn JW, Hur SY, Woo JW, et al. Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial. Lancet Oncol 2020; 21 : 1653–60. [CrossRef] [PubMed] [Google Scholar]
  6. Palmer CD, Rappaport AR, Davis MJ, et al. Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results. Nat Med 2022; 28 : 1619–29. [CrossRef] [PubMed] [Google Scholar]
  7. Rojas LA, Sethna Z, Soares KC, et al. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature 2023 : 1–7. [Google Scholar]
  8. Karaki S, Blanc C, Tran T, et al. CXCR6 deficiency impairs cancer vaccine efficacy and CD8+ resident memory T-cell recruitment in head and neck and lung tumors. J Immunother Cancer 2021; 9 : e001948. [CrossRef] [PubMed] [Google Scholar]
  9. TanoueT, MoritaS, PlichtaDR, et al. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature 2019 ; 565 : 600–605. [CrossRef] [PubMed] [Google Scholar]
  10. Derosa L, Routy B, Desilets A et al. Microbiota-centered interventions: The next breakthrough in immuno-oncology? Cancer Discov 2021; 10 : 2396–412. [CrossRef] [PubMed] [Google Scholar]
  11. Tagliamonte M, Cavalluzzo B, Mauriello A, et al. Molecular mimicry and cancer vaccine development. Mol Cancer 2023; 22 : 75. [CrossRef] [PubMed] [Google Scholar]
  12. GebhardtC, NemethJ, AngelP, et al. S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 2006 ; 72 : 1622–1631. [CrossRef] [PubMed] [Google Scholar]
  13. Lynn DJ, Benson SC, Lynn MA, et al. Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms. Nat Rev Immunol 2022; 22 : 33–46. [CrossRef] [PubMed] [Google Scholar]
  14. AtarashiK, TanoueT, ShimaT, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011 ; 331 : 337–341. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.